Abstract
Background
The natural course of central retinal artery occlusion (CRAO) often leads to legal blindness in the affected eye. To date, none of the conservative therapies had proven effective in retrospective studies. In 1991, a new minimally invasive therapy was started in patients with an acute CRAO. This therapy, namely, local intra-arterial fibrinolysis, is comparable to the minimally invasive therapy in patients with an acute ischemic stroke. In pilot studies, it showed promising results in comparison with conservative treatments. The efficacy of this method is now being investigated in a randomized multicenter study.
Methods
The European Assessment Group for Lysis in the Eye (EAGLE) started a prospective and randomized multicenter study in 2002 to evaluate therapeutic efficacy. Inclusion criteria are age between 18 and 75 years and a CRAO not older than 20 h with a visual acuity less than 0.32. The most important exclusion criteria are branch retinal artery occlusion (BRAO), cilioretinal arteries supplying the macula, and serious general disease. After randomization the patient is treated by conservative or local intra-arterial lysis therapy. The conservative regime included bulbus massage, lowering intraocular pressure with topical beta-blocker and acetazolamide, acetylsalicylic acid, heparin, and—depending on the hematocrit—isovolemic hemodilution. In case of local intra-arterial fibrinolysis, a maximum of 50 mg rtPA is injected into the ophthalmic artery by the neuroradiologist. During the following 5 days, all patients are treated with heparin. Primary study end point is visual acuity 1 month after therapy in comparison with visual acuity before therapy. The calculated sample size is 100 patients per subtrial (a total of 200 patients). The study was started in June 2002. To April 2005, 47 patients were included.
Conclusions
The EAGLE Study is the first randomized prospective clinical trial to compare conservative medical treatment and local intra-arterial fibrinolysis in patients with CRAO. The results of this study should enable ophthalmologists and neuroradiologists to improve the therapy of patients with acute CRAO. To April 2005, treatment is only justified in randomized multicenter studies because of the limited therapeutical visual outcome. We welcome new study centers to join.
Similar content being viewed by others
References
Aisenbrey S, Krott R, Heller R, Krauss D, Rossler G, Heimann K (2000) Hyperbaric oxygen therapy in retinal artery occlusion. Ophthalmologe 97:461–467
Arend O, Hoberg A, Bertram B, Reim M, Wolf S (1991) Hemodilution in acute arterial circulatory disorders of the retina. Acta Medica Austriaca 18:66–68 (German)
Arnold M, Koerner U, Remonda L, Nedeltchev K, Mattle H, Schroth G, Sturzenegger M, Weber J, Koerner F (2005) Comparison of intra-arterial thrombolysis with conventional treatment in patients with acute central retinal artery occlusion. J Neurol Neurosurg Psychiatry 76:196–199
Atebara NH, Brown GC, Cater J (1995) Efficacy of anterior chamber paracentesis and Carbogen in treating acute nonarteritic central retinal artery occlusion. Ophthalmology 102:2029–2034; discussion 2034–5
Augsburger JJ, Magargal LE (1980) Visual prognosis following treatment of acute central retinal artery obstruction. Br J Ophthalmol 64:913–917
Beatty S, Au Eong KG (2000) Local intra-arterial fibrinolysis for acute occlusion of the central retinal artery: a meta-analysis of the published data. Br J Ophthalmol 84:914–916
Brown GC, Magargal LE (1982) Central retinal artery obstruction and visual acuity. Ophthalmology 89:14–19
Campbell M, Julios S, Altmann D (1995) Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons. BMJ 311:1145–1148
Castelbuono A, Rizzo J (1995) Distribution of human photoreceptors, retinal ganglion cells and area of the striate cortex applied to Goldmann field charts. Invest Ophthalmol Vis Sci 36(Suppl):455
David NJ, Norton EW, Gass JD, Beauchamp J (1967) Fluorescein angiography in central retinal artery occlusion. Arch Ophthalmol 77:619–629
De Potter P, Zografos L (1993) Survival prognosis of patients with retinal artery occlusion and associated carotid artery disease. Graefe Arch Clin Exp Ophthalmol 231:212–216
Duker JS, Brown GC (1988) Recovery following acute obstruction of the retinal and choroidal circulations. A case history. Retina 8:257–260
Duker JS, Sivalingam A, Brown GC, Reber R (1991) A prospective study of acute central retinal artery obstruction. The incidence of secondary ocular neovascularization. Arch Ophthalmol 109:339–342
Feltgen N, Schmidt D, Hansen LL (2003) Retinale arterielle Verschlüsse. Ophthalmologe 100:651–667
Ferris F, Kassoff A, Bresnick G, Bailey I (1982) New visual acuity charts for clinical research. Am J Ophthalmol 94:91–96
Ffytche T, Bulpitt C, Kohner E, Archer D, Dollery C (1974) Effects of changes in intraocular pressure on the retinal microcirculation. Br J Ophthalmol 58:514–522
Ffytche TJ (1974) A rationalization of treatment of central retinal artery occlusion. Trans Ophthalmol Soc UK 94:468–479 (Review, 24 refs.)
Framme C, Spiegel D, Roider J, Sachs HG, Lohmann CP, Butz B, Link J, Gabel VP (2001) Central retinal artery occlusion. Importance of selective intra-arterial fibrinolysis. Ophthalmologe 98:725–730. (German)
Frayser R, Hickam J (1964) Retinal vascular response to breathing increased carbon dioxide and oxygen concentrations. Invest Ophthalmol Vis Sci 3:427–431
Gold D (1977) Retinal arterial occlusion. Trans Am Acad Ophthalmol Otolaryngol 83:OP392–OP408. (Review, 73 refs.)
Gubitz G, Sandercook P, Counsell C (2001) Antiplatelet therapy for acute ischaemic stroke. The Cochrane Library
Hayreh SS (2005) Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Retin Eye Res 24:493–519
Hayreh SS, Weingeist TA (1980) Experimental occlusion of the central artery of the retina. IV: retinal tolerance time to acute ischaemia. Br J Ophthalmol 64:818–825
Iwafune Y, Yoshimoto H (1980) Clinical use of pentoxifylline in haemorrhagic disorders of the retina. Pharmatherapeutica 2:429–438
Karjalainen K (1971) Occlusion of the central retinal artery and retinal branch arterioles. A clinical, tonographic and fluorescein angiographic study of 175 patients. Acta Ophthalmologica 109:1–96
Kieswetter H, Korber N, Jung F, Reim M (1983) Rheologic findings in patients with acute central retinal artery occlusion. Graefe Arch Clin Exp Ophthalmol 220:92–95
Kogure S, Iijima H (1991) Retinal arterial obstruction and systemic disorders. Acta Soc Ophthalmol Jap 95:67–72. (Japanese)
Landers M (1978) Retinal oxygenation via the choroidal circulation. Trans Am Ophthalmol Soc 76:528–556
Lang GE, Spraul CW (1997) Risk factors for retinal occlusive diseases. Klin Mbl Augenheilkd 211:217–226. (Review, 89 refs., German)
Lindenstrom E, Boysen G, Nyboe J (1993) Risk factors for stroke in Copenhagen, Denmark. I. Basic demographic and social factors. Neuroepidemiology 12:37–42
Lindenstrom E, Boysen G, Nyboe J (1993) Risk factors for stroke in Copenhagen, Denmark. II. Life-style factors. Neuroepidemiology 12:43–50
Lindenstrom E, Boysen G, Nyboe J, Appleyard M (1992) Stroke incidence in Copenhagen, 1976–1988. Stroke 23:28–32
Margo CE, Mack WP (1996) Therapeutic decisions involving disparate clinical outcomes: patient preference survey for treatment of central retinal artery occlusion. Ophthalmology 103:691–696
Neubauer AS, Mueller AJ, Schriever S, Gruterich M, Ulbig M, Kampik A (2000) Minimally invasive therapy for clinically complete central retinal artery occlusion-results and meta-analysis of literature. Klin Mbl Augenheilkd 217:30–36. (German)
Reboussin D, DeMets D, Kim K, Lan K (2000) Computations for group sequential boundaries using the Lan-De-Mets spending function method. Control Clin Trials 2121:190–207
Richard G, Lerche RC, Knospe V, Zeumer H (1999) Treatment of retinal arterial occlusion with local fibrinolysis using recombinant tissue plasminogen activator. Ophthalmology 106:768–773
Rumelt S, Dorenboim Y, Rehany U (1999) Aggressive systematic treatment for central retinal artery occlusion. Am J Ophthalmol 128:733–738. (Erratum appears in Am J Ophthalmol 2000 Dec;130(6):908)
Schmidt D (1996) The incomplete central retinal artery occlusion. Neuro-ophthalmology 16:171–182
Schmidt D, Schumacher M (1999) Lokale intraaterielle Fibrinolyse bei Zentralarterienverschluß (intra-arterial fibrinolysis in 51 patients with central retinal artery occlusion). Klin Mbl Augenheilkd 2:205–212
Schmidt D, Schumacher M, Wakhloo AK (1992) Microcatheter urokinase infusion in central retinal artery occlusion. Am J Ophthalmol 113:429–434
Schmidt DP, Schulte-Monting J, Schumacher M (2002) Prognosis of central retinal artery occlusion: local intraarterial fibrinolysis versus conservative treatment. Am J Neuroradiol 23:1301–1307
Schumacher M, Schmidt D, Wakhloo AK (1991) Intra-arterial fibrinolysis in central artery occlusion. Radiologe 31:240–243
Schumacher M, Schmidt D, Wakhloo AK (1993) Intra-arterial fibrinolytic therapy in central retinal artary occlusion (CRAO). Neuroradiology 35:600–605
Sharma S, Brown M, Brown G (1998) Retinal artery occlusions. Ophthalmol Clin North Am 11:591–600
Tsai F, Wadley D, Angle J, Alfieri K, Byars S (1990) Superselective ophthalmic angiography for diagnostic and therapeutic use. Am J Neuroradiol 11:1203–1204
Vulpius K, Höh H, Lange H, Maercker W, Rühle H (1996) Selektive perkutane transluminale Lysetherapie mit r-TPA bei retinalem Zentralarterienverschluß. Ophthalmologe 93:149–153
Weber J, Remonda L, Mattle HP, Koerner U, Baumgartner RW, Sturzenegger M, Ozdoba C, Koerner F, Schroth G (1998) Selective intra-arterial fibrinolysis of acute central retinal artery occlusion. Stroke 29:2076–2079
Weill A, Cognard C, Piotin M, Laloum L, Castaings L, Moret J (1998) Persistent value of intra-arterial fibrinolysis 8 hours or more following central retinal artery occlusion or of its branches. J Fr Ophtalmol 21:466–470
Wolf S, Hoberg A, Bertram B, Jung F, Kiesewetter H, Reim M (1989) Video fluorescein angiography follow-up of patients with retinal artery occlusion. Klin Mbl Augenheilkd 195:154–160. (German)
Acknowledgements
Supported by the Deutsche Forschungsgesellschaft and Boehringer Ingelheim Pharma KG
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
The study was presented at the German Ophthalmological Society (DOG) meeting 2004.
Participants
Participants
Principal investigators: M. Schumacher, H. Brückmann, A. Kampik, T. Reinhard
Study coordinator: H Maier-Lenz
End-point committee (fluorescence angiographic, photographic, and VF readers): D. Schmidt, N. Feltgen, AS Neubauer, A. Wolf
Study centers, neuroradiologists, and ophthalmologists in alphabetical order for the EAGLE Study :
Department/institution | Neuroradiologists | Ophthalmologists |
---|---|---|
Aachen | A. Thron | P. Walter, A. Weinberger |
Bern/Ch | G. Schroth, L. Remonda | S. Wolf, S. Griesser |
Bonn | H. Urbach | F. Holz, N. Eter, A. Vogel, E. Lehrer |
Essen | M. Forsting | N. Bornfeld, H. Akgül |
Freiburg | A. Berlis, I. Mader, J. Spreer | T. Reinhard, D. Schmidt, J. Hua, Th. Jehle, H. Agostini |
Hamburg/UKL | H. Zeumer | G. Richard, V. Knospe |
Hamburg/Altona | A. Leppin | K. Elze, Elze jun., Neumann |
Hannover | F. Götz | R. Winter, H. Becker, H. Schäfer |
Homburg/Saar | W. Reith | K. Ruprecht, U. Löw, K. Kohlhof |
Innsbruck | W. Jaschke, Waldenberger, A. Chemelli | W. Göttinger, B. Teuchner |
Kiel | O. Jansen | J. Roider, G. Grütters, J. Reichelt |
Lübeck | D. Petersen | H. Laqua, C Kusserow, C Schröder |
Mainz | P. Stoeter | N. Pfeiffer, D Freytag, E Hoffmann, S. Pitz |
München | H. Brückmann | A. Kampik, A. Wolf |
Wien | K. Heimberge | U. Schmidt-Erfurt, A. Reittner |
Würzburg | L. Solymosi | F. Grehn, Schrader, K. Kampik, I. Wimmer |
Rights and permissions
About this article
Cite this article
Feltgen, N., Neubauer, A., Jurklies, B. et al. Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE Study report no. 1. Graefe's Arch Clin Exp Ophthalmo 244, 950–956 (2006). https://doi.org/10.1007/s00417-005-0140-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-005-0140-2